Prof Ludwig talks to ecancertv at ICMM 2016 about treating elderly patients based on their biological rather than chronological age. 

He argues that types and dose levels of treatments should be administered based on a patient's specific state of health and fitness, rather than discriminatory assumptions based on age-related stereotypes.

Prof Ludwig also stresses the importance of patients being more assertive and involving themselves more in treatment decisions, with the support of family and friends where possible.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content